These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2895495)

  • 21. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
    Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
    J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do you spell relief in reflux esophagitis? PPI!
    Fennerty MB
    Gastroenterology; 1996 Sep; 111(3):826-7. PubMed ID: 8780593
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cisapride versus ranitidine in reflux esophagitis].
    Janisch HD
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():67-9; discussion 77-8. PubMed ID: 2192508
    [No Abstract]   [Full Text] [Related]  

  • 24. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 26. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPIs vs H2RAs for erosive reflux esophagitis.
    King VJ
    J Fam Pract; 1998 Mar; 46(3):199-200. PubMed ID: 9519012
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.
    Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG
    Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term therapy for reflux esophagitis.
    Tytgat GN
    N Engl J Med; 1995 Oct; 333(17):1148-50. PubMed ID: 7565956
    [No Abstract]   [Full Text] [Related]  

  • 30. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R
    J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
    [No Abstract]   [Full Text] [Related]  

  • 31. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary gastro-oesophageal reflux disease and irritable oesophagus syndrome as causes of recurrent abdominal pain in children.
    Corrado G; Cavaliere M; Frandina G; Rea P; Pacchiarotti C; Capocaccia P; Cardi E
    Ital J Gastroenterol; 1996; 28(8):462-9. PubMed ID: 9032590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [H2-blockers in reflux-esophagitis].
    Berstad A
    Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1439-41. PubMed ID: 6138879
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study.
    Paterson WG; Wang H; Beck IT
    Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical treatments in the short-term management of reflux esophagitis.
    Guirguis-Blake J
    Am Fam Physician; 2008 Mar; 77(5):620. PubMed ID: 18350759
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
    Koop H; Arnold R
    Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Maintenance therapy in reflux esophagitis].
    Katsoulis S; Fölsch UR
    Z Gastroenterol; 1997 Feb; 35(2):159-61. PubMed ID: 9163230
    [No Abstract]   [Full Text] [Related]  

  • 39. Propulsid (cisapride).
    Claussen DW
    Gastroenterol Nurs; 1994 Apr; 16(5):235-6. PubMed ID: 8193188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF; Gubernatis G; Siewert JR
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.